Resuscitation Devices Market Overview & Scope

The Resuscitation Devices Market size was valued at USD 8.33 billion in 2024 and is expected to reach USD 12.05 billion by 2032, growing at a CAGR of 4.74% over 2025-2032.

The resuscitation devices market has been propelled by the growing prevalence of cardiac arrest, respiratory failure, and neonatal emergencies, as well as technological breakthroughs and increasing legislative requirements. The American Heart Association reported that over 356,000 occurrences of out-of-hospital cardiac arrest happen every year in the US, while the survival rates remain abysmally low at about 10%, indicating the significance of defibrillation and CPR in addressing critical incidents.

On a global scale, about 17.9 million people die of cardiovascular diseases, adding to the market demand for resuscitation equipment, explained AHA. A study published in JAMA Cardiology and PMC points to increasing COPD-linked hospitalizations and post-COVID-19 respiratory complications are other drivers of the growing demand for resuscitation tools such as BVMs and mechanical ventilators. Moreover, increased government and institutional funding in public-access AED programs is indicated by the AHA. According to them, the number of AEDs reached about 4.5 million globally in 2023. Furthermore, recalls, such as the FDA’s Class I recall of neonatal resuscitators and Vyaire Medical’s emergency recall of BVMs, personify the focus on product safety and efficacy. Life-saving technology is also being propelled to the limits of innovation by R&D advancement, including AI models of neonatal resuscitation devices published in Scientific Reports in 2025, and NIH’s next-generation defibrillation devices.

Resuscitation Devices Market Dynamics

Drivers:

• Rising Demand and Technological Advancements Fuel Growth

The resuscitation devices market is largely driven by the rising incidence of life-threatening medical emergencies such as cardiac arrests and respiratory failures. More than 60,000 cardiac events occur in UK hospitals every year, and patients’ chances of surviving are “heavily reliant” on intervention, according to the Resuscitation Council UK. The American Heart Association states that providing CPR by bystanders can almost double or triple a patient’s chance of living, necessitating a rising requirement for automated external defibrillators and manual ones.

For instance, according to a PMC study, the rising incidence of post-pandemic respiratory troubles has redoubled the necessity for advanced ventilation technologies.

Regulatory support, such as the FDA’s 2023 AED usability improvement recommendations, has the potential to inspire novel innovations, while NIH-backed research is focused on next-generation resuscitation inventions like AI-facilitated CPR devices. Additionally, progress in public health infrastructure investment, such as a nationwide AED registry in Germany, stimulates development. Private R&D investment seems to be growing, with businesses such as Stryker and Medtronic developing portable AI-integrated resuscitation kits to enhance the efficiency of emergency response.

Restraints:

• High Costs and Regulatory Hurdles Limit Adoption

Nevertheless, the resuscitation devices market is challenged by factors such as high device prices and strict regulatory demands. While the cost of some advanced AEDs with real-time feedback can exceed USD 2,000 per unit and is not affordable for many low-income settings, some BVMs have lately been recalled by the FDA due to quality issues. It indicates that difficulties in manufacturing complicate the process of bringing new solutions to the market. The issue is exacerbated by poor standardization of certification procedures in the EU, particularly under MDR guidelines, which leads to lengthy market entry processes and negatively impacts the willingness of small device makers to create and sell new technology.

The lack of standardized training programs also affects the ability of end-users to deploy life-saving devices effectively. There are also market barriers created by disruptions in the supply chain, such as the one that occurred due to a silicone shortage. Growing R&D investment is balanced by a high level of failure of smart resuscitation devices in clinical trials, which creates financial risks for developers. All these factors prevent the broad adoption of new technology even in conditions of growing demand.

Resuscitation Devices Market Segmentation Analysis

By Product

In terms of the product, external defibrillators accounted for 55% of the market share in 2024 due to their role in managing cardiac arrest. Automated external defibrillators are highly popular in public locations and healthcare settings thanks to various regulations, such as the EU-wide Public Access Defibrillation programs and the AHA’s recommendations on community readiness in sudden cardiac arrest. The growing use of voice-guided options and real-time CPR feedback also contributes to the product’s prevalence. The airway management device has become the fastest-growing segment, with an 18% growth rate annually. As a result, COPD and post-COVID emergencies requiring respiratory assistance are driving the product’s adoption. Video laryngoscopes and disposable bag-valve masks are the most common innovative approaches to ensure responsibility among paramedics and emergency physicians in pre-hospital and intensive care settings.

By Patient Type

Adult patients held 70% of the overall market size, as cardiac arrests and respiratory failures are more common in this age group. According to AHA data, 90% of such arrests occur in those over 40, and an aging population and increasing instances of heart disease continue to fuel demand. On the other hand, pediatric patients are the fastest-growing at 12% annual growth due to rising concentration on neonatal resuscitation and complications arising from preterm birth. T-piece resuscitators and carbon dioxide detectors are becoming increasingly used in the NICU, bolstered by revised Neobattlefield resuscitation protocols (NRP).

By End User

The hospitals & cardiac centers segment was the largest, with a 60% market share in 2024, dominated by high-volume emergency cases and critical care requirements. Moreover, it has wide-ranging resuscitation capacities, incorporating cutting-edge life support systems, rendering it a superior end-user. Nevertheless, the Prehospital Care Settings segment experiences the most rapid increment by 22% every year, supported by the broadening and strengthening of EMS systems and neighborhood AED projects. Additionally, the segment is propelled by paramedics and first responders because of small, mobile resuscitation apparatuses, including lightweight defibrillators, airway kits, and so forth.

Resuscitation Devices Market Regional Outlook

In 2024, North America led the resuscitation devices market on account of advanced healthcare infrastructure, high incidence of cardiac arrest, and a large number of leading medical device manufacturers. North America accounted for approximately 42.1% of the global market share.

The U.S. resuscitation devices market size was valued at USD 2.65 billion in 2024 and is expected to reach USD 3.57 billion by 2032, growing at a CAGR of 3.86% over 2025-2032. The U.S. accounted for over 85.0% of North America’s market share owing to a high number of emergency medical procedures, public access to AEDs, and government-sponsored CPR and resuscitation programs. Canada also makes a significant contribution from nationwide EMS upgrades and training programs. Mexico is recording steady growth due to the increasing quality of emergency services and rising investment in hospital infrastructure. The U.S. is the fastest-growing country due to rising awareness of sudden cardiac arrests and a high rate of adoption of advanced airway management.

Europe is the second-largest stakeholder in the world share in the resuscitation devices market, supported by extensive public access to health services, high requirements for patient safety, and well-developed emergency medicine and resuscitation. The region contributed approximately 27.6% to the world share in 2024. Germany is the leading nation, holding about 24% due to the high number of surgical operations and the size of the medical sector investments. France and the UK are well-established players, conducting nationwide cardiac arrest promotion events and placing many AEDs nationwide. Poland is the fastest-growing country in the region due to the adoption of public-private cooperation in health care and investment in emergency response. The rest of Europe is a slow adopter, but it specifically applies to Eastern Europe, where EU money is diverted for healthcare development.

Asia Pacific is the fastest-growing regional market for resuscitation devices, supported by growing healthcare infrastructures, increased medical tourism, and rising cases of cardiovascular disorders. The region is anticipated to record the highest growth rate from 2025 to 2032, courtesy of large population sizes and advanced emergency response systems. China leads the region with a 36.2% market share while dominating urban hospital networks and strong government EMT investments. India follows China’s lead with increasing numbers of cardiac centers and public-private partnerships responsible for resuscitation training. Japan has also reported widespread resuscitation devices owing to its aging population and tech-backed healthcare systems. South Korea and Singapore are quickly emerging as portable resuscitation equipment hubs, supporting stiff competition within the region.

Key Players in the Resuscitation Devices Market:

The resuscitation devices market features key players including Asahi Kasei Corporation, Cardinal Health, Ambu A/S, ICU Medical, Teleflex Incorporated, Drägerwerk AG, Stryker Corporation, Koninklijke Philips N.V., Nihon Kohden Corporation, Vyaire Medical, Medtronic plc, ZOLL Medical Corporation, Smiths Medical, GE Healthcare, and ResMed Inc., driving innovation in life-saving medical technologies.

Recent Developments in Resuscitation Devices Market:

• In March 2024, Philips introduced its latest automated external defibrillator (AED) with AI-powered real-time CPR guidance and enhanced durability for public spaces, featuring adaptive algorithms that improve compression accuracy by 15% compared to previous models.

• In November 2023, Dräger's new E-Vent emergency ventilator received 510(k) clearance, offering auto-adjusting PEEP controls and Bluetooth-enabled vital sign monitoring specifically designed for EMS and ICU resuscitation scenarios.